Events
The Potential Impact of the New Supreme Court Justice on FDA
October 8, 2020

On October 8, Axinn associate Alex Alfano spoke at a virtual Luncheon Table Topic Discussion entitled, "The Potential Impact of the New Supreme Court Justice on FDA" at the FDLI Annual Conference: Exploring Advanced Topics in Food and Drug Law.

Speakers discussed the potential impact a new supreme court justice could have on overturning or scaling back agency deference and on eliminating the Affordable Care Act and the effect that would have on the biosimilar industry.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.